Both in Pharmaceuticals
Mineralys Therapeutics vs Pacira BioSciences
Over the past year MLYS returned −57.5% and PCRX returned +64.2%; their daily moves had a correlation of 0.08.
MLYS −57.5% PCRX +64.2%Growth of $1, one year, split-adjusted
| Metric | MLYS | PCRX |
|---|---|---|
| Price | $16.67 | $36.43 |
| Market cap | $1.47B | $1.45B |
| Today | +4.22% | +0.10% |
| 1 month | −24.1% | +47.1% |
| 6 months | −44.7% | +53.8% |
| Year to date | −54.1% | +40.7% |
| 1 year | −57.5% | +64.2% |
| Revenue growth (YoY) | — | +6.2% |
| Gross margin | — | 77.0% |
| Net margin | — | 2.4% |
| P/E (TTM) | — | 99.3× |
| Price / sales | — | 1.9× |
| Net cash | $563.8M | -$112.1M |
| Dividend yield | — | — |
| Volatility (60d) | 73.1% | 78.5% |
| Short % of float | 11.6% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).